Baba, Vevencio, JR.. S.
HRN: 14-66-82 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/26/2023
06/02/2023
IV
4.5g
TID
Empiric
Checking Final Appropriateness
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes